Species Barrier Assessment
Species Barrier Assessment - Related Videos
11:41
Assessing Transmissible Spongiform Encephalopathy Species Barriers with an In Vitro Prion Protein Conversion Assay
0 Views •
2015
Measuring the barrier to the interspecies transmission of prion diseases is challenging and typically involves animal challenges or biochemical assays. Here, we present an in vitro prion protein conversion assay with the ability to predict species barriers.
03:01
Assessing Blood-Brain Barrier Integrity in a Laser-Induced Brain Injury Rat Model
0 Views •
2025
Source: Kuts, R. et al. Laser-Induced Brain Injury in the Motor Cortex of Rats. J. Vis. Exp. (2020)This video demonstrates assessing blood-brain barrier (BBB) integrity following laser-induced brain injury in rats. A tracking dye is injected into the tail vein, allowing it to circulate to the brain and leak into the tissue through the damaged BBB. The brain is then extracted and processed to release the dye. The fluorescence intensity of the dye is measured to quantify the extent of...
07:18
Oral Gavage in Neonatal Mouse Pups and Functional Assessment of Gut Barrier Integrity Using Ussing Chambers
0 Views •
2026
This article describes: (1) oral gavage delivery of test molecules to neonatal mice as early as DOL 6; and (2) ex vivo evaluation of colonic epithelial barrier function in biopsies from DOL 10 to weaning (DOL 20) pups by assessing paracellular and transcellular permeability with Ussing chambers.
10:36
In Vitro Assays to Assess Blood-brain Barrier Mesh-like Vessel Formation and Disruption
0 Views •
Cited by 6 •
2017
Maintaining blood-brain barrier coverage is key for the homeostasis of the central nervous system. This protocol describes in vitro techniques to delineate the fundamental and pathological processes that modulate blood-brain barrier coverage.
09:38
Assessing Species-specific Contributions To Craniofacial Development Using Quail-duck Chimeras
0 Views •
Cited by 21 •
2014
This article describes a method to generate chimeric embryos that are designed to test the species-specific contributions of neural crest and/or other tissues to craniofacial development.
FAQs
Receptor compatibility can determine whether a pathogen or therapeutic agent attaches to and enters cells of another species. If the relevant receptor differs in structure, availability, or tissue distribution, cellular entry may be reduced or prevented. Comparing these features helps explain why an agent may function in one species but show limited activity or transmission potential in another.
Tissue tropism describes the tissues or cell types that an agent can affect, while host temperature can influence whether biological processes operate efficiently. Differences in either factor may limit cellular infection, therapeutic activity, or replication after entry. Assessing them together gives a more complete picture than evaluating receptor compatibility alone.
Innate immune responses can create an additional barrier after an agent reaches host cells. Species may differ in how strongly these early defenses restrict replication or biological activity, even when cellular entry is possible. Including innate immune responses in comparisons helps distinguish a failure of entry from a failure to persist or replicate effectively.
Assessments compare experimental or clinical data between species, focusing on receptor compatibility, cellular entry, tissue tropism, host temperature, innate immune responses, and replication efficiency. No single measurement necessarily captures the entire barrier. Combining these observations helps identify which biological steps differ across species and clarifies limitations in interpreting results from one species.
The analysis can help researchers identify animal species whose biological characteristics more closely reflect the human factors relevant to a pathogen, therapy, or tissue. Examining entry, tissue targeting, immune responses, and replication efficiency reveals where a model may be informative or limited. This supports more cautious interpretation of preclinical findings before human translation.
For xenotransplantation and biologic therapies, cross-species differences can affect whether transplanted tissue or an agent functions as intended in humans. Evaluating compatibility and host responses helps identify translation limits and potential safety concerns. These analyses also support medical decision-making by showing where evidence from another species may not predict human outcomes reliably.